Tulisokibart Induces Clinical Remission in Moderate-to-Severely Active Ulcerative Colitis
1. In this randomized controlled trial, among patients with moderately to severely active...
Read MoreOct 4, 2024
1. In this randomized controlled trial, among patients with moderately to severely active...
Read MoreOct 4, 2024
1. In this randomized clinical trial, adults with an alcohol use disorder (AUD) receiving either...
Read MoreOct 2, 2024
1. Major cardiac events were significantly lower in the OCT-guided group compared to the...
Read MoreOct 2, 2024
1. Treatment of desmoid tumours with dual anti-CTLA-4 and anti-PD-1 blockade with ipilimumab and...
Read MoreOct 1, 2024
1. The 5-year OS rate for pembrolizumab vs placebo was 86.1% vs 81.7% with HR 0.51 (significant)....
Read MoreOct 1, 2024
1. In this randomized controlled trial, patients with metabolic syndrome who underwent...
Read MoreOct 1, 2024
1. In this randomized controlled trial, in patients diagnosed with migraine, it was found that...
Read MoreSep 26, 2024
1. Ticagrelor was non-inferior to DAPT for the incidence of major adverse cardiovascular and...
Read MoreSep 25, 2024
1. Patients in the semaglutide group reported fewer heart failure events than those in the placebo...
Read MoreSep 24, 2024
1. Ponsegromab at increasing doses resulted in a mean increase in body weight compared to placebo;...
Read MoreSep 19, 2024
1. In two cohorts from the UK Biobank and the National Health and Nutrition Examination Survey...
Read MoreSep 18, 2024
1. In this cohort study involving noncirrhotic patients with chronic hepatitis B, a new prognostic...
Read MoreSep 18, 2024
1. In a randomized double-blind placebo-controlled study, naldemedine use was associated with...
Read MoreSep 15, 2024
1. In veterans with spinal cord injuries, exoskeletons showed no clear benefits (medical, physical...
Read MoreSep 14, 2024
1. Machine learning (ML) models developed by Lehmann and colleagues used driving characteristics...
Read MoreSep 14, 2024
1. GFAP, UCH-L1, NfL, and t-tau are all promising plasma biomarkers that show sex specific changes...
Read MoreSep 13, 2024
1. Chronic pain syndromes including fibromyalgia, dry eye disease, and irritable bowel syndrome...
Read MoreSep 11, 2024
1. Patients with HIV treated with antiretroviral therapy (ART) have a 31.5% chance of being...
Read MoreSep 10, 2024
1. Median PFS (5.6 months vs 5.6 months) and median OS (21.4 months vs 18.1 months) were similar...
Read MoreSep 10, 2024
1. In a large cohort of individuals with disorders of consciousness exhibiting no observable...
Read More